Literature DB >> 10221165

Prion protein and species barriers in the transmissible spongiform encephalopathies.

S A Priola1.   

Abstract

In the transmissible spongiform encephalopathies (TSE), the conversion of the normal protease-sensitive host protein PrP-sen to an abnormal protease-resistant form, PrP-res, is a critical step in disease pathogenesis. Amino acid mismatches between PrP-sen and PrP-res can dramatically affect the amount of PrP-res made and modulate the resistance to cross-species transmission of TSE infectivity. Experiments in transgenic mice, tissue culture cells, and cell-free systems have been used to identify the regions in PrP important in PrP-res formation. These studies have all shown that homology in the middle third of the PrP molecule is critical for the species-specific formation of PrP-res. Polymorphisms within this region correlate with the resistance of hamsters and some goats to scrapie and bovine spongiform encephalopathy (BSE) while homology at critical amino acid residues might facilitate cross-species transmission of BSE to humans. Studies such as these have proven invaluable in understanding the molecular basis of species barriers in the TSE as well as the important secondary structures involved in the formation of PrP-res.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221165     DOI: 10.1016/s0753-3322(99)80057-2

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  15 in total

1.  Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.

Authors:  S A Priola; J Chabry; K Chan
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Insights into prion biology: integrating a protein misfolding pathway with its cellular environment.

Authors:  Susanne DiSalvo; Tricia R Serio
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

3.  The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).

Authors:  Jessie A Turnbaugh; Ursula Unterberger; Paula Saá; Tania Massignan; Brian R Fluharty; Frederick P Bowman; Michael B Miller; Surachai Supattapone; Emiliano Biasini; David A Harris
Journal:  J Neurosci       Date:  2012-06-27       Impact factor: 6.167

4.  Isolation and characterization of a polymerized prion protein.

Authors:  Bao-Yuan Lu; Jui-Yoa Chang
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 5.  The role of genetics in chronic wasting disease of North American cervids.

Authors:  Stacie J Robinson; Michael D Samuel; Katherine I O'Rourke; Chad J Johnson
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

Review 6.  Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies.

Authors:  Suzette A Priola; Ina Vorberg
Journal:  Mol Biotechnol       Date:  2006-05       Impact factor: 2.695

7.  Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform.

Authors:  I Vorberg; K Chan; S A Priola
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 8.  Protein folding pathology in domestic animals.

Authors:  Erik Gruys
Journal:  J Zhejiang Univ Sci       Date:  2004-10

9.  Prion protein on astrocytes or in extracellular fluid impedes neurodegeneration induced by truncated prion protein.

Authors:  Brent Race; Kimberly Meade-White; Richard Race; Frank Baumann; Adriano Aguzzi; Bruce Chesebro
Journal:  Exp Neurol       Date:  2009-03-28       Impact factor: 5.330

10.  Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor.

Authors:  James C Geoghegan; Michael B Miller; Aimee H Kwak; Brent T Harris; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.